Audit 413409

FY End
2025-12-31
Total Expended
$2.37M
Findings
0
Programs
8
Year: 2025 Accepted: 2026-09-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.838 LUNG DISEASES RESEARCH $684,472 Yes 0
93.077 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH $325,578 Yes 0
93.837 CARDIOVASCULAR DISEASES RESEARCH $278,049 Yes 0
93.866 AGING RESEARCH $264,466 Yes 0
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $141,872 Yes 0
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $56,738 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $52,089 Yes 0
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $9,138 Yes 0

Contacts

Name Title Type
QEMHDDHERR74 Jason Liebel Auditee
3156247497 Jill Johnson Auditor
No contacts on file

Notes to SEFA

Basis of Presentation: The accompanying schedule of expenditures of federal awards (SEFA) presents the activity of all federal award programs administered by Masonic Medical Research Laboratory, dba Masonic Medical Research Institute (the Institute), an entity defined in Note 1 to the Institute's basic consolidated financial statements. Federal awards received directly from federal agencies, as well as federal awards passed through from other governmental agencies and nonprofit organizations, are included on the SEFA. Expenditures are calculated as required by the Uniform Guidance or the applicable program and do not constitute actual program disbursement. Basis of Accounting: The Institute uses the accrual basis of accounting for each federal program, consistent with the consolidated financial statements. The amounts reported as federal expenditures generally were obtained from the appropriate federal financial reports for the applicable programs and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program, which are periodically reconciled with the Institute's financial reporting system. Indirect Costs: The Institute has elected not to use the de minimis indirect cost rate as allowed under the Uniform Guidance. Rather, the Institute applies an indirect cost rate as permitted by the grant agreements.